103 related articles for article (PubMed ID: 8470238)
1. Cyclosporine vs OKT3 prophylaxis after orthotopic liver transplantation.
Pons JA; Bueno F; Parrilla P; Ramirez P; Bixquert V; Robles R; Miras M; Rodriguez J
Transplant Proc; 1993 Apr; 25(2):1949. PubMed ID: 8470238
[No Abstract] [Full Text] [Related]
2. High-dose cyclosporine A induction therapy in liver transplant recipients with normal postoperative renal function: a prospective study.
Cherqui D; Duvoux C; Salvat A; Lauzet JY; Metreau JM; Julien M; Fagniez PL; Dhumeaux D
Transplant Proc; 1995 Feb; 27(1):1134-5. PubMed ID: 7878824
[No Abstract] [Full Text] [Related]
3. A comparison of azathioprine and cyclosporine in liver transplantation: a study of two personal series.
Krom RA; Wiesner RH; Haagsma EB; Ludwig J; Gips CH; Grond AJ; Houthoff HJ
Transplant Proc; 1987 Feb; 19(1 Pt 3):2440-2. PubMed ID: 3079085
[No Abstract] [Full Text] [Related]
4. Incidence and outcome of OKT3 treatment for early steroid-resistant rejection following hepatic transplantation.
Lange D; Bechstein WO; Blumhardt G; Lemmens P; Schattenfroh N; Neuhaus P
Transplant Proc; 1993 Apr; 25(2):1870-1. PubMed ID: 8470207
[No Abstract] [Full Text] [Related]
5. OKT3 prophylaxis in liver transplant patients: a European and Australian multicenter, prospective controlled trial.
Höckerstedt K; Ericzon BG; Bismuth H; Chapuis Y; Farges O; Faure JL; Galmarini D; Houssin D; Lynch SV; Miguet J
Transplant Proc; 1993 Feb; 25(1 Pt 1):556-7. PubMed ID: 8438412
[No Abstract] [Full Text] [Related]
6. Presence of different T and B-peripheral blood lymphocyte subsets in liver transplantation after cyclosporine or OKT3 immunosuppressive treatment.
Minguela A; Alvarez-López MR; Sánchez-Bueno F; Torío A; Muro M; Robles R; Pons JA; Parrilla P; García-Alonso AM
Transplant Proc; 1995 Aug; 27(4):2317-8. PubMed ID: 7652825
[No Abstract] [Full Text] [Related]
7. Early steroid-resistant rejection following orthotopic liver transplantation: new aspects of treatment with FK 506 instead of OKT3?
Dé P; Bechstein WO; Blumhardt G; Lange D; Schattenfroh N; Neuhaus P
Transplant Proc; 1993 Aug; 25(4):2693-4. PubMed ID: 7689279
[No Abstract] [Full Text] [Related]
8. Selective amphotericin B prophylaxis in the reduction of fungal infections after liver transplant.
Mora NP; Klintmalm G; Solomon H; Goldstein RM; Gonwa TA; Husberg BS
Transplant Proc; 1992 Feb; 24(1):154-5. PubMed ID: 1539220
[No Abstract] [Full Text] [Related]
9. Conversion from Sandimmune to Neoral in stable liver graft recipients.
Pollard SG; Lodge JP
Transplant Proc; 1996 Aug; 28(4):2244-6. PubMed ID: 8769213
[No Abstract] [Full Text] [Related]
10. FK 506 improves recovery of bile secretion following orthotopic liver transplantation in man.
Söderdahl G; Groth CG; Angelin B; Duraj F; Einarsson K; Ericzon BG
Transplant Proc; 1995 Feb; 27(1):1125. PubMed ID: 7533362
[No Abstract] [Full Text] [Related]
11. FK 506 rescue therapy: the rapidity of rejection reversal is related to the subsequent development of CMV disease.
Woodle ES; Perdrizet GA; So S; Jendrisak MD; White HM; Marsh JW
Transplant Proc; 1993 Apr; 25(2):1992-3. PubMed ID: 7682360
[No Abstract] [Full Text] [Related]
12. Cytomegalovirus prophylaxis with ganciclovir, acyclovir, and CMV hyperimmune globulin in liver transplant patients receiving OKT3 induction.
Ham JM; Shelden SL; Godkin RR; Posner MP; Fisher RA
Transplant Proc; 1995 Oct; 27(5 Suppl 1):31-3. PubMed ID: 7482814
[No Abstract] [Full Text] [Related]
13. Posttransplant lymphoproliferative disorders in liver recipients treated with OKT3 or ALG induction immunosuppression.
McAlister V; Grant D; Roy A; Yilmaz Z; Ghent C; Wall W
Transplant Proc; 1993 Feb; 25(1 Pt 2):1400-1. PubMed ID: 8442154
[No Abstract] [Full Text] [Related]
14. Quadruple-drug therapy with antithymocyte globulin in the early postoperative period after liver transplantation.
Schattenfroh N; Lange D; Bechstein WO; Blumhardt G; Lohmann R; Neuhaus P
Transplant Proc; 1993 Apr; 25(2):1968-9. PubMed ID: 8470245
[No Abstract] [Full Text] [Related]
15. Use of OKT3 for late acute rejection in liver transplantation.
Samuel D; Gugenheim J; Canon C; Saliba F; Bismuth H
Transplant Proc; 1990 Aug; 22(4):1767-8. PubMed ID: 2117804
[No Abstract] [Full Text] [Related]
16. Immunosuppression for recipients of kidneys from non-heart-beating donors: comparison of triple therapy and OKT3 regimens.
Kehinde EO; Wheatley T; Feehally J; Nicholson ML; Veitch PS; Bell PR
Transplant Proc; 1996 Jun; 28(3):1338-9. PubMed ID: 8658684
[No Abstract] [Full Text] [Related]
17. Intensive care after orthotopic liver transplantation.
Sun CK; Chen CL; Kuo YC; Chen YS
Transplant Proc; 1994 Aug; 26(4):2246-7. PubMed ID: 7520627
[No Abstract] [Full Text] [Related]
18. Long-term effect of cyclosporine on renal function in children after liver transplantation.
Bilik R; Superina RA; Hu X
Transplant Proc; 1993 Aug; 25(4):2578-9. PubMed ID: 8356677
[No Abstract] [Full Text] [Related]
19. Effect of cyclosporine dosing on creatinine levels in hepatic transplant recipients.
Gross CR; Savik SK; Ascher NL; Gordon RD; Klintmalm GB; Payne W; Shaw BW; Strasburg K; Parker A; Wiesner RH
Transplant Proc; 1994 Oct; 26(5):2686-90. PubMed ID: 7940841
[No Abstract] [Full Text] [Related]
20. Comparison of the long-term tolerability, pharmacodynamics, and safety of Sandimmune and Neoral in liver transplant recipients. Ontario Liver Transplant Study Group.
Grant D; Rochon J; Levy G
Transplant Proc; 1996 Aug; 28(4):2232-3. PubMed ID: 8769208
[No Abstract] [Full Text] [Related]
[Next] [New Search]